Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Study Identifier
1698-301-007
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
2022-502380-37-00
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.
Study Locations
Location
Status
Location
Horizon Eye Specialists & Lasik Centers /ID# 235240
Sun City, Arizona, United States, 85351
Status
Not applicable
Location
Atlantis Eye Care /ID# 235530
Huntington Beach, California, United States, 92647
Status
Not applicable
Location
Lakeside Vision Center /ID# 234970
Irvine, California, United States, 92604
Status
Not applicable
Location
Global Research Foundation /ID# 237350
Los Angeles, California, United States, 90041-1718
Status
Not applicable
Location
The Eye Research Foundation /ID# 234521
Newport Beach, California, United States, 92663-3637
Status
Not applicable
Location
Byers Eye Institute Stanford /ID# 235544
Palo Alto, California, United States, 94303
Status
Not applicable
Showing {first} - {last} of {total} Results